Skip to main content

Table 1 Demographic and clinical characteristics of the sample

From: An international mixed methods study to develop a new preference-based measure for women with breast cancer: the BREAST-Q Utility module

 

Qualitative interviews

N = 57

Cognitive interviews

N = 9

Characteristic

N

%

N

%

Site of recruitment

    

Canada—JCC

22

39

6

67

Canada—TGH

21

37

3

33

United States—MSK

14

25

0

0

Stage of breast cancer

    

Stage 0

9

16

1

11

Stage 1

15

26

2

22

Stage 2

20

35

5

56

Stage 3

10

18

1

11

Stage 4

3

5

0

0

Age in years

    

Young adult (18–39)

2

4

0

0

Middle-aged adult (40–59)

39

68

6

67

Old adult (60 and above)

16

28

3

33

Race/ethnicity

    

White

45

79

7

78

Black or African American

2

4

1

11

Asian

5

9

1

11

Other

5

9

0

0

BMI category

    

Underweight—< 18.5

2

4

1

11

Normal—18.5 to 24.9

21

37

2

22

Overweight—25 to 29.9

24

42

4

44

Obese—30 and higher

10

18

2

22

Marital status

    

Married/living common law

43

75

8

89

Single, never married

4

7

0

0

Divorced/separated/widowed

10

18

1

11

Employment

    

Employed, full-time

24

42

3

33

Employed, part-time

12

21

3

33

Unemployed

2

4

0

0

Homemaker

3

5

0

0

Sick leave/disabled

3

5

0

0

Retired

11

19

1

11

Other

2

4

2

22

Total annual household income (previous year)

    

0–25,000

5

9

0

0

25,000–50,000

5

9

0

0

50,000–75,000

8

14

2

22

 > 75,000

31

54

7

78

Prefer not to say

8

14

0

0

Education

    

High school graduate or equivalent

10

18

2

22

Some college/university (less than 4 years)

13

23

2

22

College/university (4-year bachelor’s degree)

28

49

4

44

Postgraduate degree (e.g., Masters, Doctorate)

6

11

1

11

Type of (neo)adjuvant treatment

    

Chemotherapy

37

65

7

78

Radiation

35

61

7

78

Hormone replacement therapy

36

63

7

78

Targeted therapy (HER2)

7

12

0

0

Type of cancer surgery

    

Breast conserving therapy

9

16

2

22

Mastectomy—Unilateral

24

42

5

56

Mastectomy—Bilateral

23

40

2

22

None

1

2

0

0

Reconstruction

N = 47

N = 7

Yes

36

77

4

 

No

11

23

3

 

Type of reconstruction

N = 36

N = 4

Autologous

26

72

2

50

Implant

10

28

2

50

Laterality

    

Unilateral

18

50

2

50

Bilateral

18

50

2

50

Timing of reconstruction

    

Immediate

21

58

2

50

Delayed

6

17

2

50

Not available

9

25

0

0

  1. JCC, Juravinski Cancer Center, TGH, Toronto General Hospital, MSK, Memorial Sloan Kettering Cancer Center, HER2, Human epidermal growth factor receptor
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us